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Letter to the Editor
CT Scanning the Coronaries for Calcium – Why the Controversy?
Dear Editor,
Few recent topics in cardiovascular medicine have
engendered as much debate as the now vexed issue of
high resolution CT scanning of the coronary arteries for
calcium, as a predictor of coronary disease risk. As
presymptomatic detection of atherosclerosis is a vital
and still unsolved problem in clinical practice, open
discussion about this topic is very important. It is equally
important, however, that clinical practitioners have a
clear idea of the 'state of the art', in order to help guide
management of individual patients.
The essential facts concerning coronary calcium
scanning are not in dispute. Non-invasive tests to assist
in risk stratification are clearly needed, for low and
intermediate-risk patients. CT scanning can detect
calcium in the coronary arteries and this is clearly a
marker of the burden of atherosclerosis in the coronary
circulation. If the coronary calcium score is '0',
subsequent risk of events in the medium turn is very low
(although not zero) and if the calcium score is high, this
clearly indicates not only the presence of extensive
atherosclerotic plaque, but also improved risk prediction,
compared with conventional risk factor assessment
only. 1 Nevertheless, despite excellent sensitivity for
disease, CT scanning for coronary calcium has much
less good specificity, resulting in a high number of 'false
positive' tests (in terms of predicting actual events). This
may cause undue concern in asymptomatic subjects and
can lead to a series of subsequent cardiac diagnostic
tests, which may have low yield. It is also not in dispute
that this is an area worthy of further investigation, and
accordingly data are accumulating rapidly about the role
of this test in clinical practice.
Against this very promising background
information, the experience in many countries, including
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Australia as well as Hong Kong, has been that the test
has been introduced to the public with occasionally with
aggressive marketing and advertising strategies, directed
at the general community. This has sometimes occurred
before the medical profession has accepted the benefits
of coronary CT scanning. Publicity such as 'the most
important advertisement you'll ever read' (or phrases
similar) has appeared in high circulation newspapers and
journals. Not surprisingly, the uptake rate by a public
well educated and concerned about the dangers of heart
disease has been high. Some subjects have been very
relieved by early detection of a high calcium score and
subsequent workup, others have been relieved by a
reassuringly negative calcium score, but many have been
worried by the news that they have 'coronary calcium',
without a clear diagnostic or therapeutic pathway for
them or their doctors to follow. Marketing direct to the
public along these lines is contrary to the more traditional
medical model with which doctors are comfortable,
wherein evidence is carefully evaluated, learned societies
and/or key opinion leaders come to a consensus, and
then information is disseminated to the public through
specialists, GPs and medically-based education.
Herein lies the genesis of some of the controversy
surrounding coronary CT scanning. Those specialists
involved in centres which have 'marketed' coronary CT
scanning have been cast by some as 'irresponsible
entrepreneurs' preying on the latent fears of a gullible
public, whereas members of the profession who have
adopted a more conservative stance can be cast as
latter-day Luddites, delaying the uptake of promising new
technologies which may have real health benefits, to the
detriment of the general community. Such tensions often
accompany the introduction of novel and exciting
technologies, but can be particularly acute when
significant sums of money can be made or lost, on the
acceptance or otherwise of expensive new techniques.
A series of excellent review articles and letters
have appeared in the Journal this year, commenting with
different degrees of enthusiasm on the burgeoning use
of electron beam CT for the non-invasive assessment
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of coronary artery calcium and its role in predicting
coronary risk.2-4 These are all sensible and well-balanced
viewpoints from highly regarded experts in the practice
of cardiovascular medicine.
How then, to find perspective on this issue?
This is an exciting area of research, about which we
will all read more in the coming years. At the time of
writing, the American College of Cardiology and the
American Heart Association have produced
consensus documents on electron beam CT for the
diagnosis and prognosis of coronary artery disease,
suggesting that this technique not be employed for
non-invasive screening of asymptomatic subjects at
risk of cardiovascular events.5 Newer data have since
been published, however, 1 which may in time result
in the revision of these recommendations, especially
if similar results can be obtained in other supportive
studies. As a community, we need to keep an open
mind about such new data, whilst vigorously protecting
our patients from unproven diagnostic and/or
therapeutic strategies.
Some other questions need to be answered about
coronary CT scanning. Firstly, cost/benefit analyses will
be important in a cost-conscious era where other
putative markers of coronary risk (such as high sensitivity
CRP assays and ultrasound measurement of arterial wall
thickness) may be considerably cheaper than CT
scanning, and not carry any radiation risk. Secondly, are
non-electron beam CT scanners as reliable, in the
detection of calcium? Most importantly of all,
cardiologists will want to have practical guidance on
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which calcium scores in which patients should prompt
which further diagnostic tests and/or treatment options.
This is an important topic, and the Journal is to be
congratulated for publishing high quality articles,
commentaries and letters on this subject. In the next 5
years, we will almost certainly find out whether coronary
CT scanning for calcium is 'hype' or 'hope'. In the interim,
a search for the right test for presymptomatic
determination of coronary risk remains a 'Holy Grail' of
internal medicine, as the worldwide prevalence of
atherosclerotic disease continues its inexorable climb.
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